French genomics software company SeqOne completed the acquisition of UK-based Congenica, combining AI-powered next-generation sequencing analysis with clinical decision support and interpretation services. The integrated platform aims to accelerate genetic diagnosis for rare diseases and precision oncology. The combined entity serves over 160 laboratories in 30 countries, with continued UK operations at the Wellcome Sanger Institute. Both firms have raised significant funding in recent years and this merger strengthens their global market presence.